腋窝超声联合化疗前阳性标记淋巴结术前导丝定位在新辅助化疗后淋巴结再分期中的初步研究
前瞻性纳入32例腋窝阳性乳腺癌新辅助化疗患者,评估腋窝超声及超声引导导丝定位化疗前阳性标记淋巴结对淋巴结反应的预测价值。腋窝超声与标记淋巴结切除联合的假阴性率总体为4.8%,在化疗前超声可疑淋巴结≤2枚的患者中为0%。结论认为联合方案对新辅助化疗后淋巴结再分期具有高诊断准确性。
要点
- 联合术后腋窝超声与化疗前阳性标记淋巴结导丝定位切除可降低假阴性率至4.8%。
- 化疗前超声可疑淋巴结≤2枚者联合方案假阴性率为0%。
- 单独标记淋巴结切除假阴性率高达28.6%,需联合腋窝超声评估。
局限性
- 单中心初步研究,样本量较小(32例)。
- 研究为初步探索性设计,结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the role of axillary ultrasonography (axUS) and ultrasound-guided pre-operative wire localisation of pre-treatment positive clipped node (CN) for prediction of nodal response to neoadjuvant chemotherapy (NACT) in node positive breast carcinoma patients.
METHODS AND MATERIALS: A prospective study was conducted between June 2018 and August 2020 after Ethics Committee approval. Breast carcinoma patients (cT1-cT4b) with palpable axillary nodes (cN1-cN3) and suitable for NACT were recruited after written informed consent. Single, most suspicious node was biopsied and clipped. Nodal response to NACT was assessed on axUS. Wire localisation of CN was performed prior to axillary lymph node dissection (ALND). Diagnostic performances of axUS and CN excision were assessed.
RESULTS: Of the 69 patients evaluated, 32 patients (mean age, 43.5 ± 11.8 years; females, 31/32 [97%]; pre-menopausal, 18/32 [56.3%]) with metastatic nodes who received NACT were included. Nodal pathological complete response rate was 34.4% (11/32) overall and 70% (7/10) in patients with ≤2 suspicious nodes on pre-NACT axUS. False-negative rates (FNRs) of axUS and CN excision were 4.8% and 28.6% respectively. Combination of post-NACT axUS and CN excision had an FNR of 4.8% overall and 0% in patients with ≤2 suspicious nodes on pre-NACT axUS.
CONCLUSION: Combination of AxUS and ultrasound-guided wire localisation of pre-treatment positive CN has high diagnostic accuracy for nodal restaging after NACT in node positive breast cancer patients.
ADVANCES IN KNOWLEDGE: Addition of axUS assessment to wire localisation of CN reduces its FNR for detecting residual metastasis after NACT.
引用
- Pulappadi VP, Paul S, Hari S, et al. Axillary ultrasonography combined with pre-operative wire localisation of clipped node in nodal restaging after neoadjuvant chemotherapy in node positive breast cancer patients: a pilot study. Br J Radiol. 2021. PMID: 34491822. doi:10.1259/bjr.20210788
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。